Latest Series B Funding Rounds
Startups financing expansion after their early institutional rounds. Explore the businesses, round sizes and investors behind the next phase.
- Rounds
- 589 All time
- Disclosed funding
- $58.6B 500 disclosed amounts
- Median round
- $46.8M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| DU Defense UnicornsCompany profile Develops secure software delivery for national security mission systems Develops secure software delivery for national security mission systems | $136M | Series B | Defense tech | United States | Investors | |
| T3 The 33rd TeamCompany profile Provides football intelligence and technology for professional and collegiate teams Provides football intelligence and technology for professional and collegiate teams | Undisclosed | Series B | Consumer | United States | Investors | |
Develops commercial all-wing aircraft. | $175M | Series B | Mobility | United States | Investors | |
| RT Reexen TechnologyCompany profile Reexen Technology develops compute-in-memory chips and systems for AI inference. Reexen Technology develops compute-in-memory chips and systems for AI inference. | Undisclosed | Series B+Series B | Hardware | China | Investors | |
| V Provides stablecoin-powered financial infrastructure for global businesses | $20M | Series B | Fintech | United States | Investors | |
| MT Mirador TherapeuticsCompany profile Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250M | Series B | Biotech | United States | Investors | |
AccelsiusCompany profile Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. | $65M | Series B | Hardware | United States | Investors | |
| JT Develops regenerative biologics to restore tissue function | $33.5M | Series B | Biotech | United States | Investors | |
| KT Develops inhaled therapies for severe respiratory diseases | $103M | Series B | Biotech | United States | Investors | |
AbbelightCompany profile Microscopy and nanoscopy systems combining chemistry, optics and analysis for life-science researchers. Microscopy and nanoscopy systems combining chemistry, optics and analysis for life-science researchers. | Undisclosed | Series B | Biotech | France | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Model ML, Garage, Infisical
23rounds0led - 2General Catalyst
Rox, Hypersonica, Collective
23rounds8led - 3Khosla Ventures
Traversal, Even Healthcare, Arena
23rounds6led - 4Andreessen Horowitz (a16z)
Tutor Intelligence, Town, Arena
22rounds4led - 5Sequoia Capital
Rox, Traversal, Nevis
20rounds4led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.